南大光電(300346.SZ)擬向上海銀行蘇州分行申請併購貸款9200萬元
格隆匯3月25日丨南大光電(300346.SZ)公佈,近日,公司與上海銀行股份有限公司蘇州分行簽訂了《借款合同》,合同約定公司向上海銀行股份有限公司蘇州分行申請併購貸款人民幣9200萬元,用於置換公司以自有資金支付的山東飛源氣體有限公司的股權收購和增資款項,貸款期限:3年;貸款利率:根據定價日公佈的全國銀行間同業拆借中心一年期貸款市場報價利率(LPR)加70個基點(一個基點為0.01%)。
此次公司申請併購貸款是基於公司實際經營情況的綜合考慮,符合公司結構化融資安排,有助於公司後續的資金使用規劃,有利於更好地支持公司業務拓展,符合公司長遠發展戰略規劃。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.